Evogene is a series a startup. 1 investor tracked. Status: possibledead.
Based in Israel, Evogene is a startup founded in 2011. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Evogene develops computational biology technologies that enable the design and development of novel products in agriculture, biotechnology, and life sciences.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.